KAPRUKA

#CRXT New Targets @$12-14.3-20 UPTO 280%

做多
NASDAQ:CRXT   None
Sector: Health Technology
Industry: Pharmaceuticals: Major


Clarus Therapeutics Holdings, Inc. is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. the company's first commercial product is JATENZO. It is headquartered in Northbrook, IL.

Target : USD 12-14.3-20
Resistance 2 : USD 10.15
Resistance 1 : USD 06.78

Support 1 : USD 3.37

**Disclaimer - This is not a financial advice, please trade with caution and on your own risk. This prediction Based on My Dreams.
Do not view this idea as a recommendation for trading or investing. Risk Only What You Can Afford. Always Use a Stop Loss. Past performance is not necessarily a guide to future performance.

I would appreciate your feedback on my analysis.

Cheers
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。